"Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The seventh volume of the book features reviews on these topics:
 
· Essential oils and monoterpenes as potential anti-cancer agents
 
· Drug delivery systems and emerging immunotherapeutic strategies for the treatment of glioblastoma
 
· CTDNA in solid tumors
 
· Cholesterol treatments (including Pitavastatin) and their potential in cancer treatment"


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 7

End User License Agreement (for non-institutional, personal use)

Essential Oils and Monoterpenes as Potential Anti-Cancer Agents

A Glance at Drug Delivery Systems and Emerging Immunotherapeutic Strategies for the Treatment of Glioblastoma

ctDNA in Solid Tumors: Role in Diagnosis, Prognosis and Treatment

Pitavastatin and Cancer: Current and Future Prospects

INTER-CORRELATION BETWEEN CHOLESTEROL TRANSPORTERS AND CELL PROLIFERATION

INTRACELLULAR CHOLESTEROL, CELL CYCLE ACTIVITY AND CELL PROLIFERATION

Cholesterol: A Steer to Cell Cycle Activity and Cell Proliferation

CHOLESTEROL HOMEOSTASIS IN CANCER TUMOUR CELLS

REPROGRAMMED CHOLESTEROL METABOLISM IN CANCER CELLS

IMMUNE CELL SUPPRESSION BY CARCINOGEN AND CARCINOMA

BIPHASIC ROLE OF CHOLESTEROL IN PROMOTING TUMOR CELL PROLIFERATION AND TUMOR DEFENSIVE IMMUNE CELL DEATH

ANTI-CANCER DRUG TARGETS: PREVENTION AGAINST INIMICAL DOUBLE-EDGED REPROGRAMMED CHOLESTEROL HOMEOSTASIS

Cholesterol: A Potential Target for Intervention in Anti-Cancer Therapy

Bentham Science Publishers

"Frontiers in Clinical Drug Research – Anti infectives is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the book series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
 
The seventh volume of this series features these interesting reviews:
- Nucleic acid and peptide aptamers as potential antiviral drugs
- Host-directed, antibiotic-adjuvant combination, and antibiotic-antibiotic combination for treating multidrug-resistant (mdr) gram-negative pathogens
- Bioactive substances as anti-infective strategies against clostridioides difficile
- Anti-toxoplasma drug discovery and natural products: a brief overview
- Development of antimalarial and antileishmanial drugs from amazonian biodiversity"


Frontiers in Clinical Drug Research - Anti Infectives: Volume 7

Atta-ur-Rahman

"Frontiers in Clinical Drug Research – Hematology is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology.
The second volume of this series features 5 chapters that cover a variety of topics including: 
-Chronic myeloid leukemia
-Bispecific and multivalent antibodies
-Natural Killer cells therapy for bone marrow transplantation 
-Nanoparticles in health and disease 
-Monoclonal antibody therapy for lymphoma"


Frontiers in Clinical Drug Research - Hematology: Volume 2

"Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer's disease (AD), a disease that causes dementia, or loss of brain function. This disease affects parts of the brain that affect memory, thought, and language. Chapters in each volume focus on drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.
 
 
 
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in the field of Alzheimer’s disease research.
 
 
 
The eighth volume of this series features chapters covering critical discussions on new therapies for AD. The reviews in this volume include:
 
- Novel Molecular Targets of Tauopathy; Therapeutic and Diagnostic Applications
 
- The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs
 
- Could Antibiotics Be Therapeutic Agents in Alzheimer’s Disease?
 
- Use of Antipsychotics in Patients with Alzheimer’s Disease
 
- Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease
 
- Potential Biological Mechanisms with Prophylactic Action in Rapid Cognitive Impairment in Late-Onset Alzheimer's Disease"



Frontiers in Clinical Drug Research - Alzheimer Disorders Volume 8

"Stem cell and regenerative medicine research is a hot area of research which promises to change the face of medicine as it will be practiced in the years to come. Challenges in the 21st century to combat diseases such as cancer, Alzheimer and related diseases may well be addressed employing stem cell therapies and tissue regeneration. Frontiers in Stem Cell and Regenerative Medicine Research is essential reading for researchers seeking updates in stem cell therapeutics and regenerative medicine. 
This volume includes reviews on the following topics: 
-the role of microvesicles and exosomes in mesenchymal stem cell (MSCs) in treating diseases while overcoming side effects
-alternative models for understanding cancer stem cell biology
-stem cells treatments for orthopaedic injury and endocrine disorders
-wound healing biomaterials
-theoretical models of hematopoietic cell dynamics (with implications for bone marrow transplants)"


Frontiers in Stem Cell and Regenerative Medicine Research: Volume 8

Shazia Anjum

Frontiers in Anti-Cancer Drug Discovery” is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.


Frontiers in Anti-Cancer Drug Discovery: Volume 2

Dr. M. lqbal Choudhary 

"Applications of NMR Spectroscopy is a book series devoted to publishing the latest advances in the applications of nuclear magnetic resonance (NMR) spectroscopy in various fields of organic chemistry, biochemistry, health and agriculture.
The fourth volume of the series features several reviews focusing on NMR spectroscopic techniques in food sciences. Readers will find references on methods used to test food quality, food color analysis, the role of Tannins in wine taste as well as NMR studies on lipid oxidation and large protein complexes."


Applications in Food Sciences

"Recent Advances in Analytical Techniques is a series of updates in techniques used in chemical analysis. Each volume presents a selection of chapters that explain different analytical techniques and their use in applied research. Readers will find updated information about developments in analytical methods such as chromatography, electrochemistry, optical sensor arrays for pharmaceutical and biomedical analysis.
 
 
 
The fifth volume of the series features five reviews which demonstrate chemical analysis techniques applied in different disciplines.
 
 
 
- Superior Aspects of Liquid Chromatography-Based Mass Spectrometers in Chiral Analysis
 
- New Trends in Sample Preparation for Pharmaceutical and Biological Analysis by Chromatographic Methods
 
- Qualitative and Quantitative Investigation of Bio Tissues using Microscopy and Data Mining
 
- Analytical Techniques For Analysis of Metals and Minerals in The Soil Samples
 
- Monitoring Therapeutic Response in Cancers: A Raman Spectroscopy Approach"


Recent Advances in Analytical Techniques Volume 5

Sibel A. Ozkan

"Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs.
The third volume of this series brings 5 reviews which cover the following topics: H1 receptor selectivity, chronic spontaneous urticaria therapy, smooth muscle cell Ca2+ signaling pathway targeting for asthma therapy, allergic rhinitis and endosomal toll-like receptors.
 
Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field."


Frontiers in Clinical Drug Research - Anti-Allergy Agents: Volume 3

"Obesity is a complex health problem, caused by a number of factors such as excessive food intake, lack of physical activity, genetic predisposition, endocrine disorders, medications and psychiatric illnesses. Onset of obesity in both the developing and the developed world has reached epidemic proportions. In response to this, efforts to control and treat obesity have also been vigorously pursued, ranging from raising awareness about lifestyle changes to the discovery and development of safe and effective anti-obesity drugs.
Anti-obesity Drug Discovery and Development is focused on this very important area of healthcare research. The third volume of this series is dedicated to anti-obesity treatments including updates on new therapeutics for obesity, Nesfatin-1 and its therapeutic uses, the role of proteomics in pediatric anti-obesity treatment, the role of oxidative stress in childhood obesity and a review of data on gut microbiota as a treatment option for obesity."


Anti-obesity Drug Discovery and Development: Volume 3

"Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. The series presents comprehensive reviews written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations or optimal product yields. Advances in Organic Synthesis is essential for all organic chemists in academia and the industry who wish to keep abreast of rapid and important developments in the field.
 
This volume presents the following reviews:
Asymmetric hydrogenation of tetrasubstituted olefins
Recent advances in catalytic organic synthesis applications of covalently supported ionic liquids
Recent developments in intramolecular cyclization reactions via carbon-heteroatom (c-x) bond formation
Efficient synthetic protocol and mechanistic study of quinazoline analogues and their biological importance
Synthesis of N,O,S-heterocycles by one-pot reactions of epoxides, aziridines and oxaziridines
 "


Your Cart

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 7

$ 79.00

Description of Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 7

Additional Information

About the authors

Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti Infectives: Volume 7

Frontiers in Clinical Drug Research - Hematology: Volume 2

Frontiers in Clinical Drug Research - Alzheimer Disorders Volume 8

Frontiers in Stem Cell and Regenerative Medicine Research: Volume 8

Frontiers in Anti-Cancer Drug Discovery: Volume 2

Applications in Food Sciences

Recent Advances in Analytical Techniques Volume 5

Frontiers in Clinical Drug Research - Anti-Allergy Agents: Volume 3

Anti-obesity Drug Discovery and Development: Volume 3

Advances in Organic Synthesis: Volume 9

Atta-ur-Rahman